Press release
Duchenne Muscular Dystrophy Treatment Market Size, Competitive Analysis, Historical & Forecast Analysis 2023-2030: Cognitive Market Research
Duchenne Muscular Dystrophy Treatment Market Size, Competitive Analysis, Historical & Forecast Analysis 2023-2030: Cognitive Marke
Duchenne muscular dystrophy (DMD) is a genetic disorder characterized by progressive muscle degeneration and weakness. It primarily affects males, with symptoms typically appearing in early childhood. DMD is caused by a mutation in the dystrophin gene, which leads to the absence or dysfunction of the dystrophin protein, an essential component for maintaining muscle integrity.
While there is no known cure for DMD, several treatment approaches aim to manage symptoms, slow disease progression, and improve the quality of life for individuals with the condition. Glucocorticoids, such as prednisone and deflazacort, are commonly prescribed to individuals with DMD. These medications have been shown to slow the progression of muscle degeneration, preserve muscle strength, and improve overall motor function. They work by reducing inflammation and promoting muscle regeneration. However, long-term use of corticosteroids can have side effects, including weight gain, delayed growth, and bone fragility.
Summary:
The Global Duchenne Muscular Dystrophy Treatment market size was $2.48 Billion in 2022.
To know more about The Duchenne Muscular Dystrophy Treatment Market statistics click here: https://www.cognitivemarketresearch.com/duchenne-muscular-dystrophy-treatment-market-report
Market Dynamics:
• Unmet need has created a strong market demand for innovative DMD treatments
The significant unmet need for Duchenne Muscular Dystrophy (DMD) treatment has created a strong market demand for innovative therapies. DMD is a devastating and progressive genetic disorder that primarily affects young boys, leading to muscle weakness, loss of ambulation, respiratory complications, and reduced life expectancy. Currently, there is no cure for DMD, and available treatments mainly focus on managing symptoms and improving quality of life. The lack of effective treatment options for DMD has resulted in a pressing need for innovative therapies that can address the underlying cause of the disease and provide better outcomes for patients.
Limited efficacy of current treatments while various interventions, such as corticosteroids and physical therapy, can help manage symptoms and slow disease progression to some extent, they do not address the root cause of DMD. These treatments have limitations in terms of their effectiveness, tolerability, and long-term benefits. Therefore, there is a demand for therapies that can more directly target the genetic mutation responsible for DMD and provide more substantial clinical benefits.
DMD significantly impacts the quality of life of patients and their families. Progressive muscle degeneration leads to severe disability, loss of ambulation, respiratory complications, and cardiac dysfunction. The current treatment options only offer partial relief and do not adequately address the overall disease burden. There is a strong market demand for therapies that can halt or slow disease progression, improve muscle function, and extend the lifespan of DMD patients.
• Higher Intake of Corticosteroids eventually boosts the market growth (Access Detailed Analysis in the Full Report Version)
• Growth of Clinical Research significantly fuels the market growth (Access Detailed Analysis in the Full Report Version)
Market Segmentation:
Type:
• Molecular-based Therapies
• Steroid Therapy
• Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
• Other
Application:
• Hospitals/Clinics
• Ambulatory Centers
• Other
Get free sample pages of latest published Duchenne Muscular Dystrophy Treatment Market Report: https://www.cognitivemarketresearch.com/duchenne-muscular-dystrophy-treatment-market-report#request_sample
Competitive Analysis for Duchenne Muscular Dystrophy Treatment Market:
• Myers Squibb Company
• NS Pharma Inc.
• Sarepta Therapeutics
• Bristol
• Eli Lilly and Company
• Nobelpharma Co. Ltd
• PTC Therapeutics
• Pfizer Inc.
• BioMarin
• Santhera Pharmaceuticals
• Fibrogen Inc.
Company Profile
• PTC Therapeutics Inc
PTC Therapeutics Inc. is US based company involved in the research and development of drugs and treatments for various health conditions. The company has a presence in different countries like Argentina, Austria, Australia, Brazil, Canada, France, Germany, Italy, Japan, Mexico, and others across the globe. Therapeutic areas of the company include metabolism, neurology, and oncology. Currently, the approved products of the company include, EMFLAZA, EVRYSDI, TEGSEDI, TRANSLARNA, UPSTAZA, and WAYLIVRA.
To know more about the Duchenne Muscular Dystrophy Treatment Market click here: https://www.cognitivemarketresearch.com/duchenne-muscular-dystrophy-treatment-market-report
Related Report:
• Oil Refining- https://www.chemicalmarketstudy.com/oil-refining-market-report
• Zero-waste Packaging- https://www.chemicalmarketstudy.com/zero-waste-packaging-market-report
• Automotive Wrap Films- https://www.chemicalmarketstudy.com/automotive-wrap-films-market-report
Infographics from Cognitive Market Research:
• Barcode Scanner- https://www.cognitivemarketresearch.com/assets/images/report_images/report_infographics/Barcode_Scanner_market_report_1681453638.jpg
Blog from Cognitive Market Research:
• Exploring the Growth Potential of the Secondary Engine Fueling Market: Chemical Market Study- https://blog.chemicalmarketstudy.com/exploring-the-growth-potential-of-the-secondary-engine-fueling-market
To view a Company Profile click here:
• DIC Corporation- https://www.chemicalmarketstudy.com/company_profile/dic-corporation
Article from Cognitive Market Research:
• Factors of Rising Curry Boil in Bag Market- https://www.cognitivemarketresearch.com/articles/factors-of-rising-curry-boil-in-bag-market
𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐔𝐬
Nicolas Shaw
Cognitive Market Research
20 N State Street,Chicago,
Illinois, 60602
United States
USA: +1 312-376-8303
Europe and UK: (+44) 20-8144-9523
Asia Pacific: (+852) 81930785
Email: sales@cognitivemarketresearch.com
Website: https://www.cognitivemarketresearch.com/about-us
About Cognitive Market Research Company :
Cognitive Market Research has evolved as one leading market research and consulting firm and it provides services across multiple domains. Cognitive Market Research gathers and analyzes data about customers, competitors, distributors, and other market actors and forces operational across the value chain. As a market research company, we follow a complete process of gathering information about the target market and end-use industries to verify the complete journey of the product or service in the global market. It helps our readers understand the demand and viability of their product/service and how it might perform in the real world and help them to build business strategies accordingly
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Duchenne Muscular Dystrophy Treatment Market Size, Competitive Analysis, Historical & Forecast Analysis 2023-2030: Cognitive Market Research here
News-ID: 3146401 • Views: …
More Releases from Cognitive Market Research
Ultra Fine Copper Powder Market is estimated to grow at a CAGR of 7.1% during th …
Market Overview:
- The term "ultra-fine copper powder" refers to a finely divided type of copper that is distinguished by its exceedingly small particle size and large surface area. It is made using a variety of processes, such as mechanical grinding, electrolysis, and chemical precipitation. Ultra-fine copper powder typically has particles between a few nanometres and a few micrometers in size.
Summary:
- As per Cognitive Market Research, Global Ultra-Fine Copper…
Premium Branding and Status Symbol boosts the Global Metal Card Market: Cognitiv …
Market Overview:
- A metal card typically refers to a credit or debit card that is made from metal materials instead of traditional plastic. These cards are often associated with premium or high-end credit card offerings and are designed to provide a more luxurious and prestigious feel. Metal cards are usually made from materials such as stainless steel, titanium, or other alloys, which gives them a solid and durable construction.…
Slot Machines Market is projected to grow at a CAGR of 12.9% within the forecast …
Market Overview:
A slot machine is operated by inserting coins into a slot and by pulling down on a long handle. It features a set of spinning reels with various symbols on them. Players or individuals insert coins or tokens into the machine and then pull a lever or press a button to activate the reels. The earliest slot machine technology was created with mechanical reels powered by random number generators.…
Mechanical Seals Market is estimated to grow at a CAGR of 4.8% within the foreca …
Market Overview:
A mechanical seal is only a way to keep fluid inside a vessel usually pumps, mixers, etc. when a rotating shaft passes through a stationary housing or, on rare occasions, when the housing rotates around the shaft. Mechanical seals are devices used to prevent leakage between two components or systems that are connected by a rotating shaft. They are commonly used in pumps, compressors, mixers, and other equipment that…
More Releases for DMD
Vishay Intertechnology Thermawick DMD Thermal Jumper Chip Removes Heat from Elec …
NORTHVALE, New Jersey, USA – New Yorker Electronics has released the Vishay’s ThermaWick™ THJP Series of Surface-mount Thermal Jumper Chips. The Vishay Dale Thin Film device allows designers to transfer heat from electrically isolated components by providing a thermal conductive pathway to a ground plane or common heatsink while maintaining the electrical isolation of the device.
Featuring an aluminum nitride substrate with high 170 W/m°K thermal conductivity, the chip released by…
Duchenne Muscular Dystrophy (DMD) Drugs Market Report
As per the research conducted by GME, the Duchenne Muscular Dystrophy (DMD) Drugs Market will grow with a CAGR value of 41.3 percent by 2026. The global market for Duchenne muscular dystrophy is foreseen to grow due to accelerated research and development activities, expanded patient awareness for effective treatments, and the launch of new medications Moreover, the disease's increasing prominence is likely to drive the global duchenne muscular dystrophy market…
Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Future Forecast 202 …
The research report focuses on target groups of customers to help players to effectively market their products and achieve strong sales in the global Duchenne Muscular Dystrophy (DMD) Therapeutics Market. It segregates useful and relevant market information as per the business needs of players. Readers are provided with validated and revalidated market forecast figures such as CAGR, Duchenne Muscular Dystrophy (DMD) Therapeutics market revenue, production, consumption, and market share. Our accurate market…
Duchenne Muscular Dystrophy (DMD) Market Strategies, Competitive Landscape and F …
An up-to-date research report has been disclosed by Market Research Hub highlighting the title “Duchenne Muscular Dystrophy (DMD): Competitive Landscape to 2026” which provides an assessment of the pipeline, clinical, and commercial landscape of DMD. Overall, MRH expects new drug approvals to drive DMD market growth over the next decade (2016-2026). Duchenne Muscular Dystrophy (DMD) is a rare, fatal recessive X-linked genetic disorder affecting predominantly males. It occurs as a…
Global Market Study On Dystrophin (DMD) - Pipeline Review, H2 2017 | MarketResea …
"The Report Dystrophin (DMD) - Pipeline Review, H2 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"
According to the recently published report 'Dystrophin (DMD) - Pipeline Review, H2 2017'; Dystrophin (DMD) pipeline Target constitutes close to 27 molecules. Out of which approximately 23 molecules are developed by companies and remaining by the universities/institutes.
Dystrophin (DMD) - Dystrophin is a cytoplasmic protein. It…
Duchenne Muscular Dystrophy (DMD) Treatment Market - Global Industry Insights, T …
Duchenne muscular dystrophy (DMD) is a genetic disorder characterized by progressive muscle degeneration and weakness. DMD is caused due to alteration in gene sequence coding for dystrophin proterin, which is present the muscle. It is a rare muscle disease which majorly affects males. The symptoms includes intellectual disability, muscle weakness and, difficulty in walking and breathing. Congestive heart failure, mental impairment, pneumonia or respiratory failure are some of the…
